Change in Salvage Radiotherapy Management Based on Guidance With FACBC (Fluciclovine) PET/CT in Postprostatectomy Recurrent Prostate Cancer-Reference-Cited by-同舟云学术

Change in Salvage Radiotherapy Management Based on Guidance With FACBC (Fluciclovine) PET/CT in Postprostatectomy Recurrent Prostate Cancer

Published:2017-01 Issue:1 Volume:42 Page:e22-e28
ISSN:0363-9762
Container-title:Clinical Nuclear Medicine
language:en
Short-container-title:

Author:

Akin-Akintayo Oladunni O.,Jani Ashesh B.,Odewole Oluwaseun,Tade Funmilayo I.,Nieh Peter T.,Master Viraj A.,Bellamy Leah M.,Halkar Raghuveer K.,Zhang Chao,Chen Zhengjia,Goodman Mark M.,Schuster David M.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Radiology Nuclear Medicine and imaging,General Medicine

Reference51 articles.

1. Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy;Freedland;JAMA,2005

2. Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer;Han;J Urol,2003

3. Delayed prostate-specific antigen recurrence after radical prostatectomy: how to identify and what are their clinical outcomes?;Caire;Urology,2009

4. Salvage radiotherapy following biochemical relapse after radical prostatectomy: proceedings of the Genito-Urinary Radiation Oncologists of Canada consensus meeting;Sia;Can Urol Assoc J,2008

5. Outcome after conformal salvage radiotherapy in patients with rising prostate-specific antigen levels after radical prostatectomy;Geinitz;Int J Radiat Oncol Biol Phys,2012

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Positron Emission Tomography/Computed Tomography;PET Clinics;2024-04

2. 18F-Fluciclovine;Radiopharmaceuticals;2024

3. Prostate Cancer—PET Imaging Update;Cancers;2023-01-28

4. Radiopharmaceuticals and contrast agents;Clinical PET/MRI;2023

5. Radical prostatectomy for patients with high-risk, very-high risk, or radiographic suspicion for metastatic prostate cancer: Perioperative and early oncologic results from the MUSIC statewide collaborative;Urologic Oncology: Seminars and Original Investigations;2022-08